March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Change in Corneal Hysteresis over Time in Normal and Glaucomatous Eyes
Author Affiliations & Notes
  • Syed A. Hussnain
    Ophthalmology, Weill Cornell Medical College, New York, New York
  • Joseph B. Alsberge
    Ophthalmology, Weill Cornell Medical College, New York, New York
  • Joshua R. Ehrlich
    Ophthalmology, Weill Cornell Medical College, New York, New York
  • Mitsugu Shimmyo
    Ophthalmology, New York Medical College, New York, New York
  • Nathan M. Radcliffe
    Ophthalmology, Weill Cornell Medical College, New York, New York
  • Footnotes
    Commercial Relationships  Syed A. Hussnain, None; Joseph B. Alsberge, None; Joshua R. Ehrlich, None; Mitsugu Shimmyo, None; Nathan M. Radcliffe, Alcon Laboratories, Inc. (C, R), Allergan, Inc. (C, R), Carl Ziess Meditec (C, R), Merck & Co., Inc. (R), Ophthalmic Imaging Systems (I, C)
  • Footnotes
    Support  Supported by Research to Prevent Blindness and a 2009 Mentoring for Advancement of Physician Scientists (MAPS) Award from the American Glaucoma Society.
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 6795. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Syed A. Hussnain, Joseph B. Alsberge, Joshua R. Ehrlich, Mitsugu Shimmyo, Nathan M. Radcliffe; Change in Corneal Hysteresis over Time in Normal and Glaucomatous Eyes. Invest. Ophthalmol. Vis. Sci. 2012;53(14):6795.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : On cross-sectional analysis, corneal hysteresis (CH) is lower with advancing age and in glaucomatous compared to healthy eyes. The aim of this study was to compare the rate of decline of CH in normal patients and patients with primary open angle glaucoma (POAG).

Methods: : Consecutive normal and POAG patients underwent assessment with the Ocular Response Analyzer (ORA; Reichert Corp., Buffalo, USA) on each office visit. Right eyes with at least 7 measurements were included for analysis. All patients with known ocular pathology other than POAG were excluded. Two sample t-tests (adjusted for unequal variance as indicated), chi-squared, and logistic regression were used to analyze data.

Results: : A total of 1418 normal and 322 POAG patients were included. POAG patients were significantly older (70.73 ± 11.33 vs. 61.59 ± 16.56 years; P<0.001), had a longer duration of follow-up (4.14 ± 1.34 vs. 2.72 ± 1.49 years; P<0.001), and lower CH (9.58 ± 2.17 vs. 9.95 ± 2.19 mmHg; P=0.01), but there were no gender differences between groups (61.5 vs. 57.7% female; p=0.21). We also observed a significantly more negative change over time in CH among POAG compared to normal patients (-0.11 ± 0.73 vs. 0.07 ± 2.31 mm Hg/year; P=0.02). The relation between ΔCH/year and diagnosis persisted after adjusting for age and follow-up time (OR 0.90; 95% CI 0.82, 0.99; p=0.03).

Conclusions: : POAG patients in this study had a significantly greater rate of CH decline compared to normal.

Keywords: cornea: clinical science • aging 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×